STAR vs VINEETLAB: Stock Comparison

Strides Pharma Science Limited vs Vineet Laboratories Limited

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Strides Pharma Science Limited is the larger company by market capitalisation. Strides Pharma Science Limited shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Strides Pharma Science Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, STAR is more favourable on 9 of 10 scored metrics and VINEETLAB on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
STAR is the larger company
₹9,626 Cr vs ₹75 Cr
EPS
STAR has higher earnings per share
₹60.31 vs ₹-20.47
Dividend Yield
STAR has a higher dividend yield
0.37% vs 0%
Revenue Growth (TTM YoY)
STAR has faster revenue growth
11.2% vs 11.05%
EPS Growth (TTM YoY)
STAR has faster EPS growth
54.4% vs 0%
Qtr Sales Growth
STAR has stronger quarterly sales growth
11.2% vs -68.8%
Qtr Profit Growth
VINEETLAB has stronger quarterly profit growth
59.2% vs 28.1%
ROCE
STAR has a higher ROCE
18.6% vs -28%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSTARVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSTARVINEETLAB
Live Price₹1,041.7₹38.55
Day Change-0.12%5.79%
Volume89,6852.02 L
52-Week High₹1,231₹49.99
52-Week Low₹768.65₹27.96
Distance from 52W High-15.38%-22.88%

Valuation

MetricSTARVINEETLAB
Market Cap₹9,626 Cr₹75 Cr
P/E Ratio17.16x
P/B Ratio3.07x
EPS₹60.31₹-20.47
Book Value₹337.09₹15.84
Dividend Yield0.37%0%

Growth

MetricSTARVINEETLAB
Revenue Growth (TTM YoY)11.2%11.05%
EPS Growth (TTM YoY)54.4%0%
Qtr Sales Growth11.2%-68.8%
Qtr Profit Growth28.1%59.2%

Profitability & Leverage

MetricSTARVINEETLAB
ROE20.4%
ROCE18.6%-28%
Net Margin10.58%-26.92%
Operating Margin19%-22.4%
Debt to Equity0.57x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSTARVINEETLAB
Promoter Holding27.91%5.98% 6.48 pp
FII Holding28.39% 0.29 pp0.36% 0.36 pp
DII Holding15.41% 0.96 pp
Public Holding28.28% 0.67 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Strides Pharma Science Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.